126 related articles for article (PubMed ID: 19969037)
1. Systemic administration of 3-nitropropionic acid points out a different role for active caspase-3 in neurons and astrocytes.
Duran-Vilaregut J; Del Valle J; Manich G; Junyent F; Camins A; Pallàs M; Pelegrí C; Vilaplana J
Neurochem Int; 2010 Feb; 56(3):443-50. PubMed ID: 19969037
[TBL] [Abstract][Full Text] [Related]
2. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
Duan W; Guo Z; Mattson MP
Exp Neurol; 2000 Sep; 165(1):1-11. PubMed ID: 10964480
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
[TBL] [Abstract][Full Text] [Related]
4. Role of matrix metalloproteinase-9 (MMP-9) in striatal blood-brain barrier disruption in a 3-nitropropionic acid model of Huntington's disease.
Duran-Vilaregut J; del Valle J; Manich G; Camins A; Pallàs M; Vilaplana J; Pelegrí C
Neuropathol Appl Neurobiol; 2011 Aug; 37(5):525-37. PubMed ID: 21175737
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways.
Lee ST; Chu K; Park JE; Hong NH; Im WS; Kang L; Han Z; Jung KH; Kim MW; Kim M
J Neurochem; 2008 Mar; 104(5):1190-200. PubMed ID: 17976163
[TBL] [Abstract][Full Text] [Related]
6. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P
Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966
[TBL] [Abstract][Full Text] [Related]
7. Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats.
Cirillo G; Maggio N; Bianco MR; Vollono C; Sellitti S; Papa M
Neurochem Int; 2010 Jan; 56(1):152-60. PubMed ID: 19799953
[TBL] [Abstract][Full Text] [Related]
8. Neuronal apoptosis in the striatum of rats treated with 3-nitropropionic acid is not triggered by cell-cycle re-entry.
Duran-Vilaregut J; Manich G; del Valle J; Pallàs M; Camins A; Pelegrí C; Vilaplana J
Neurotoxicology; 2011 Dec; 32(6):734-41. PubMed ID: 21827787
[TBL] [Abstract][Full Text] [Related]
9. Kaempferol protects against rat striatal degeneration induced by 3-nitropropionic acid.
Lagoa R; Lopez-Sanchez C; Samhan-Arias AK; Gañan CM; Garcia-Martinez V; Gutierrez-Merino C
J Neurochem; 2009 Oct; 111(2):473-87. PubMed ID: 19682208
[TBL] [Abstract][Full Text] [Related]
10. Involvement of nitric oxide in 3-nitropropionic acid-induced striatal toxicity in rats.
Deshpande SB; Hida H; Takei-Io N; Masuda T; Baba H; Nishino H
Brain Res; 2006 Sep; 1108(1):205-15. PubMed ID: 16857175
[TBL] [Abstract][Full Text] [Related]
11. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production.
Villarán RF; Tomás-Camardiel M; de Pablos RM; Santiago M; Herrera AJ; Navarro A; Machado A; Cano J
Neurotoxicology; 2008 Mar; 29(2):244-58. PubMed ID: 18093658
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome c oxidase isoform IV-2 is involved in 3-nitropropionic acid-induced toxicity in striatal astrocytes.
Singh S; Misiak M; Beyer C; Arnold S
Glia; 2009 Nov; 57(14):1480-91. PubMed ID: 19306371
[TBL] [Abstract][Full Text] [Related]
13. Caspase-3 activation in astrocytes following postnatal excitotoxic damage correlates with cytoskeletal remodeling but not with cell death or proliferation.
Acarin L; Villapol S; Faiz M; Rohn TT; Castellano B; González B
Glia; 2007 Jul; 55(9):954-65. PubMed ID: 17487878
[TBL] [Abstract][Full Text] [Related]
14. Metabolic compromise with systemic 3-nitropropionic acid produces striatal apoptosis in Sprague-Dawley rats but not in BALB/c ByJ mice.
Alexi T; Hughes PE; Knüsel B; Tobin AJ
Exp Neurol; 1998 Sep; 153(1):74-93. PubMed ID: 9743569
[TBL] [Abstract][Full Text] [Related]
15. Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats.
Al Mutairy A; Al Kadasah S; Elfaki I; Arshaduddin M; Malik D; Al Moutaery K; Tariq M
Neurotoxicol Teratol; 2010; 32(2):226-33. PubMed ID: 19755148
[TBL] [Abstract][Full Text] [Related]
16. Distinct spatial and temporal activation of caspase pathways in neurons and glial cells after excitotoxic damage to the immature rat brain.
Villapol S; Acarin L; Faiz M; Castellano B; Gonzalez B
J Neurosci Res; 2007 Dec; 85(16):3545-56. PubMed ID: 17668855
[TBL] [Abstract][Full Text] [Related]
17. Lack of Jun-N-terminal kinase 3 (JNK3) does not protect against neurodegeneration induced by 3-nitropropionic acid.
Junyent F; de Lemos L; Verdaguer E; Pallàs M; Folch J; Beas-Zárate C; Camins A; Auladell C
Neuropathol Appl Neurobiol; 2012 Jun; 38(4):311-21. PubMed ID: 21883373
[TBL] [Abstract][Full Text] [Related]
18. A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo.
Yang L; Sugama S; Mischak RP; Kiaei M; Bizat N; Brouillet E; Joh TH; Beal MF
Neurobiol Dis; 2004 Nov; 17(2):250-9. PubMed ID: 15474362
[TBL] [Abstract][Full Text] [Related]
19. IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
Escartin C; Boyer F; Bemelmans AP; Hantraye P; Brouillet E
Neurosci Lett; 2007 Oct; 425(3):167-72. PubMed ID: 17868993
[TBL] [Abstract][Full Text] [Related]
20. Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease.
Ramaswamy S; McBride JL; Herzog CD; Brandon E; Gasmi M; Bartus RT; Kordower JH
Neurobiol Dis; 2007 May; 26(2):375-84. PubMed ID: 17336076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
